Literature DB >> 25685763

Conservative strategy for treatment of stable coronary artery disease.

Paulo Cury Rezende1, Thiago Luis Scudeler1, Leandro Menezes Alves da Costa1, Whady Hueb1.   

Abstract

Patients with coronary artery disease vary widely in terms of prognosis, which is mainly dependent on ventricular function. In relation to the major outcomes of death and myocardial infarction, it is not clear in the literature if an invasive strategy of myocardial revascularization is superior to a conservative strategy of optimized medical therapy. Moreover, with the exception of patients with left main coronary disease, this similarity in prognosis also occurs in different subgroups of patients.

Entities:  

Keywords:  Angina pectoris; Coronary angioplasty; Coronary artery disease; Disease-free survival; Myocardial infarction; Myocardial revascularization; Prognosis

Year:  2015        PMID： 25685763      PMCID： PMC4317610          DOI： 10.12998/wjcc.v3.i2.163

Source DB:  PubMed          Journal:  World J Clin Cases        ISSN： 2307-8960            Impact factor:   1.337


  34 in total

1.  Ten-year follow-up survival of the Medicine, Angioplasty, or Surgery Study (MASS II): a randomized controlled clinical trial of 3 therapeutic strategies for multivessel coronary artery disease.

Authors:  Whady Hueb; Neuza Lopes; Bernard J Gersh; Paulo R Soares; Expedito E Ribeiro; Alexandre C Pereira; Desiderio Favarato; Antonio Sérgio C Rocha; Alexandre C Hueb; Jose A F Ramires
Journal:  Circulation       Date:  2010-08-23       Impact factor: 29.690

2.  Eighteen-year follow-up in the Veterans Affairs Cooperative Study of Coronary Artery Bypass Surgery for stable angina.

Authors: 
Journal:  Circulation       Date:  1992-07       Impact factor: 29.690

3.  Impact of diabetes on five-year outcomes of patients with multivessel coronary artery disease.

Authors:  Whady Hueb; Bernard J Gersh; Fernando Costa; Neuza Lopes; Paulo R Soares; Paulo Dutra; Fabio Jatene; Alexandre C Pereira; Aécio F T Góis; Sergio A Oliveira; José A F Ramires
Journal:  Ann Thorac Surg       Date:  2007-01       Impact factor: 4.330

4.  Impact of ischaemia and scar on the therapeutic benefit derived from myocardial revascularization vs. medical therapy among patients undergoing stress-rest myocardial perfusion scintigraphy.

Authors:  Rory Hachamovitch; Alan Rozanski; Leslee J Shaw; Gregg W Stone; Louise E J Thomson; John D Friedman; Sean W Hayes; Ishac Cohen; Guido Germano; Daniel S Berman
Journal:  Eur Heart J       Date:  2011-01-21       Impact factor: 29.983

5.  Survival after coronary revascularization in the elderly.

Authors:  Michelle M Graham; William A Ghali; Peter D Faris; P Diane Galbraith; Colleen M Norris; Merril L Knudtson
Journal:  Circulation       Date:  2002-05-21       Impact factor: 29.690

6.  Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS).

Authors: 
Journal:  N Engl J Med       Date:  1987-06-04       Impact factor: 91.245

7.  A comparison of angioplasty with medical therapy in the treatment of single-vessel coronary artery disease. Veterans Affairs ACME Investigators.

Authors:  A F Parisi; E D Folland; P Hartigan
Journal:  N Engl J Med       Date:  1992-01-02       Impact factor: 91.245

8.  Impact of diabetes on 10-year outcomes of patients with multivessel coronary artery disease in the Medicine, Angioplasty, or Surgery Study II (MASS II) trial.

Authors:  Eduardo Gomes Lima; Whady Hueb; Rosa Maria Rahmi Garcia; Alexandre Costa Pereira; Paulo Rogério Soares; Desiderio Favarato; Cibele Larrosa Garzillo; Ricardo D'Oliveira Vieira; Paulo Cury Rezende; Myrthes Takiuti; Priscyla Girardi; Alexandre Ciappina Hueb; José A F Ramires; Roberto Kalil Filho
Journal:  Am Heart J       Date:  2013-06-15       Impact factor: 4.749

9.  Results of coronary artery surgery in patients with poor left ventricular function (CASS).

Authors:  E L Alderman; L D Fisher; P Litwin; G C Kaiser; W O Myers; C Maynard; F Levine; M Schloss
Journal:  Circulation       Date:  1983-10       Impact factor: 29.690

10.  A randomized comparative study of patients undergoing myocardial revascularization with or without cardiopulmonary bypass surgery: The MASS III Trial.

Authors:  Whady Hueb; Neuza H M Lopes; Bernard J Gersh; Cláudio C Castro; Felipe S Paulitsch; Sergio A Oliveira; Luis A Dallan; Alexandre C Hueb; Noedir A Stolf; José A F Ramires
Journal:  Trials       Date:  2008-08-28       Impact factor: 2.279
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.